Proposed Data Collections Submitted for Public Comment and Recommendations, 9922-9923 [2013-03193]
Download as PDF
<![CDATA[
9922
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
(2) determine whether the exposure
control plan or other resource is actively
used to prevent occupational exposures;
(3) determine available resources and
barriers to use such as relevant
educational materials, knowledge, costs,
availability; and
(4) develop strategies to overcome key
barriers to compliance.
The Organization for Safety, Asepsis
and Prevention (OSAP) is a unique
group of dental educators and
consultants, researchers, clinicians,
industry representatives, and other
interested persons with a collective
mission to be the world’s leading
advocate for the safe and infection-free
delivery of oral healthcare. OSAP
supports this commitment to dental
knowledge, costs, and availability.
There are no costs to the respondents
other than their time. OSAP is working
with a publishing partner that has an
email distribution list of 45,419 dentists,
representing every state in the country.
The list represents nearly one-third
(32%) of the total population of working
dentists in the United States.
The targeted number of completed
questionnaires is estimated at about
22,700 (50% participation rate). The
survey is estimated to take about 15
minutes for respondents to complete.
This survey completion scenario yields
an annualized hour burden estimate of
5,675 hours.
There are no costs to respondents
other than their time.
workers and the public through quality
education and information
dissemination. OSAP’s unique
membership includes the variety of
partners critical to gather the data on
compliance with the OSHA bloodborne
pathogens standard, identify barriers
and develop strategies to overcome
barriers to compliance.
OSAP will be conducting a web
survey of private dental practices in the
United States. Information collected
will include an inventory of existing
exposure control plans; whether the
plan or other resource is actively used
to prevent occupational exposure to
bloodborne pathogens; available
resources and barriers to use such as
relevant education materials,
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Private Dental Practices ...................
BBP Exposure Control Plan Survey
Total ..................................................
...........................................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013–03180 Filed 2–11–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0041]
tkelley on DSK3SPTVN1PROD with NOTICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Kimberly S. Lane, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
15/60
5,675
........................
........................
........................
5,675
Registration of individuals with
Amyotrophic Lateral Sclerosis (ALS) in
the National ALS Registry—Revision—
(0923–0041, Expiration 7/31/2013)—
Agency for Toxic Substances and
Disease Registry (ATSDR), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
On October 10, 2008, President Bush
signed S. 1382: ALS Registry Act which
amended the Public Health Service Act
to provide for the establishment of an
Amyotrophic Lateral Sclerosis (ALS)
Registry. The activities described are
part of the effort to create the National
ALS Registry. The purpose of the
registry is to: (1) Better describe the
incidence and prevalence of ALS in the
United States; (2) examine appropriate
factors, such as environmental and
occupational, that might be associated
Frm 00040
Fmt 4703
Total burden
(in hrs)
1
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
PO 00000
Avg. burden
per response
(in hrs)
22,700
Proposed Project
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Number of
responses per
respondent
Sfmt 4703
with the disease; (3) better outline key
demographic factors (such as age, race
or ethnicity, gender, and family history)
associated with the disease; and (4)
better examine the connection between
ALS and other motor neuron disorders
that can be confused with ALS,
misdiagnosed as ALS, and in some cases
progress to ALS. The registry will
collect personal health information that
may provide a basis for further scientific
studies of potential risks for developing
ALS.
After piloting methodology, on
October 18, 2010, the Agency for Toxic
Substances and Disease Registry
(ATSDR) launched the registration
component of the National ALS Registry
www.cdc.gov/als.
The registration portion of the data
collection is limited to information that
can be used to identify an individual to
assure that there are not duplicate
records for an individual. Avoiding
duplication of registrants due to
obtaining records from multiple sources
is imperative to get accurate estimates of
incidence and prevalence, as well as
accurate information on demographic
characteristics of the cases of ALS.
In addition to questions required for
registration, there are a series of short
surveys to collect information on such
things as military history, occupations,
residential history, and family history
that would not likely be available from
other sources.
E:\FR\FM\12FEN1.SGM
12FEN1
9923
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
This project proposes to continue
collecting information on individuals
with ALS which can be combined with
information obtained from existing
sources of information and add
additional optional risk factor surveys.
This combined data will become the
National ALS Registry and will be used
to provide more accurate estimates of
the incidence and prevalence of disease
as well as the demographic
characteristics of the cases. Information
obtained from the surveys will be used
to better characterize potential risk
factors for ALS which will lead to
further in-depth studies.
The existence of the Web site has
been advertised by ATSDR and
advocacy groups such as the
Amyotrophic Lateral Sclerosis
Association (ALSA) and the Muscular
Dystrophy Association (MDA).
There are between 15,000 and 30,000
individuals living with ALS at any
given time. In addition, approximately
6,000 people are diagnosed with ALS
each year and we expect about onequarter of them will participate in the
registry. Because an advantage to
registration is participating in the
surveys, we expect the one time
surveys, and the twice yearly survey
participation rate will be 50%.
There are no costs to the respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Person with ALS ................
Validation questions (Screener) for suspected
ALS cases.
Registration Form of ALS cases .....................
Cases of ALS completing 1-time surveys ......
Cases of ALS completing twice yearly
surveys*.
.........................................................................
Total ............................
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
1670
1
2/60
56
1500
750
750
1
16
2.7
7/60
5/60
5/60
175
1000
169
........................
........................
........................
1400
* The disease progression survey is taken initial and then 3 times the first year (3, 6, 12 months after the initial survey). Because some people’s disease progresses more rapidly, clinicians recommended adding the survey at 3 months to make sure everyone had the opportunity to
take the survey a second time. In years 2 and 3, the survey would be taken at 6 and 12 months.
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013–03193 Filed 2–11–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Proposed Data Collections Submitted
for Public Comment and
Recommendations
tkelley on DSK3SPTVN1PROD with NOTICES
[60Day-13–13GX]
Assessment of a Comprehensive
Human immunodeficiency virus (HIV)
Clinic-Based Intervention to Promote
Patients’ Health and Reduce
Transmission Risk—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
Background and Brief Description
CDC is requesting Office of
Management and Budget (OMB)
approval to collect data that will be
used to evaluate an HIV clinic-based
intervention to increase the number of
HIV patients who (1) have undetectable
levels of HIV in their blood, (2) adhere
optimally to antiretroviral therapy
(ART), (3) attend clinic regularly for
primary care, and (4) practice safer sex.
These are objectives of the National
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
HIV/AIDS Strategy and goals of the
strategic plan of the Division of HIV/
AIDS Prevention, Centers for Disease
Control and Prevention.
The project will be conducted at six
HIV clinics in the United States. This
proposed data collection will occur over
3 years.
The intervention that is part of this
project focuses primarily on HIV
patients who have a detectable viral
load, i.e., their viral load is not as low
as it can be and is not fully controlled.
The intervention components include:
(1) Brief counseling from medical
providers during primary care visits
informed by a behavioral screener
completed by patients; (2) a computerbased intervention (CBI) in which
patients see short videos of HIV medical
providers (not their own providers)
talking about the importance of regular
clinic attendance, adherence to ART,
and safer sex; and (3) one-on-one
counseling from a prevention specialist
if needed.
The following data will be collected
in this project:
• A data manager at each clinic will
electronically transmit patient clinical
data to CDC using a unique study
identification code as the only means of
identifying a patient’s data. The data
files sent to CDC will not contain any
medical record numbers, names, or
social security numbers. The
information will be encrypted and
stored in a secure CDC server. The data
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Pages 9922-9923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03193]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0041]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Kimberly S. Lane, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Registration of individuals with Amyotrophic Lateral Sclerosis
(ALS) in the National ALS Registry--Revision--(0923-0041, Expiration 7/
31/2013)--Agency for Toxic Substances and Disease Registry (ATSDR),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
On October 10, 2008, President Bush signed S. 1382: ALS Registry
Act which amended the Public Health Service Act to provide for the
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The
activities described are part of the effort to create the National ALS
Registry. The purpose of the registry is to: (1) Better describe the
incidence and prevalence of ALS in the United States; (2) examine
appropriate factors, such as environmental and occupational, that might
be associated with the disease; (3) better outline key demographic
factors (such as age, race or ethnicity, gender, and family history)
associated with the disease; and (4) better examine the connection
between ALS and other motor neuron disorders that can be confused with
ALS, misdiagnosed as ALS, and in some cases progress to ALS. The
registry will collect personal health information that may provide a
basis for further scientific studies of potential risks for developing
ALS.
After piloting methodology, on October 18, 2010, the Agency for
Toxic Substances and Disease Registry (ATSDR) launched the registration
component of the National ALS Registry www.cdc.gov/als.
The registration portion of the data collection is limited to
information that can be used to identify an individual to assure that
there are not duplicate records for an individual. Avoiding duplication
of registrants due to obtaining records from multiple sources is
imperative to get accurate estimates of incidence and prevalence, as
well as accurate information on demographic characteristics of the
cases of ALS.
In addition to questions required for registration, there are a
series of short surveys to collect information on such things as
military history, occupations, residential history, and family history
that would not likely be available from other sources.
[[Page 9923]]
This project proposes to continue collecting information on
individuals with ALS which can be combined with information obtained
from existing sources of information and add additional optional risk
factor surveys. This combined data will become the National ALS
Registry and will be used to provide more accurate estimates of the
incidence and prevalence of disease as well as the demographic
characteristics of the cases. Information obtained from the surveys
will be used to better characterize potential risk factors for ALS
which will lead to further in-depth studies.
The existence of the Web site has been advertised by ATSDR and
advocacy groups such as the Amyotrophic Lateral Sclerosis Association
(ALSA) and the Muscular Dystrophy Association (MDA).
There are between 15,000 and 30,000 individuals living with ALS at
any given time. In addition, approximately 6,000 people are diagnosed
with ALS each year and we expect about one-quarter of them will
participate in the registry. Because an advantage to registration is
participating in the surveys, we expect the one time surveys, and the
twice yearly survey participation rate will be 50%.
There are no costs to the respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hours)
respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Person with ALS................................ Validation questions (Screener) for 1670 1 2/60 56
suspected ALS cases.
Registration Form of ALS cases......... 1500 1 7/60 175
Cases of ALS completing 1-time surveys. 750 16 5/60 1000
Cases of ALS completing twice yearly 750 2.7 5/60 169
surveys*.
Total...................................... ....................................... .............. .............. .............. 1400
--------------------------------------------------------------------------------------------------------------------------------------------------------
* The disease progression survey is taken initial and then 3 times the first year (3, 6, 12 months after the initial survey). Because some people's
disease progresses more rapidly, clinicians recommended adding the survey at 3 months to make sure everyone had the opportunity to take the survey a
second time. In years 2 and 3, the survey would be taken at 6 and 12 months.
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-03193 Filed 2-11-13; 8:45 am]
BILLING CODE P
